Kala Pharmaceuticals (KALA) Reports Q2 Loss of $4.36
Tweet
Share
E-mailGet Alerts KALA Hot Sheet
Join SI Premium – FREE
Kala Pharmaceuticals (NASDAQ: KALA) reported Q2 EPS of ($4.36).
For earnings history and earnings-related data on Kala Pharmaceuticals (KALA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
